(FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
---|---|---|---|---|
Cash flow from operating activities | ||||
Earning before tax | 98.13%80.42M | 1,232.60%40.59M | 85.85%3.05M | --1.64M |
Profit adjustment | ||||
Interest (income) - adjustment | -63.77%-1.02M | -3,781.25%-621K | -433.33%-16K | ---3K |
Attributable subsidiary (profit) loss | -48.56%232K | 105.15%451K | -373.22%-8.76M | ---1.85M |
Impairment and provisions: | 1.04%2.52M | --2.49M | ---- | ---- |
-Impairment of trade receivables (reversal) | 0.76%2.51M | --2.49M | ---- | ---- |
-Other impairments and provisions | --7K | ---- | ---- | ---- |
Revaluation surplus: | 31.15%-42K | ---61K | ---- | ---- |
-Other fair value changes | 31.15%-42K | ---61K | ---- | ---- |
Asset sale loss (gain): | -2,493.33%-778K | -100.53%-30K | --5.66M | ---- |
-Loss (gain) from sale of subsidiary company | ---779K | ---- | --5.66M | ---- |
-Loss (gain) on sale of property, machinery and equipment | 103.33%1K | ---30K | ---- | ---- |
Depreciation and amortization: | 2.10%44.89M | --43.97M | ---- | ---- |
-Amortization of intangible assets | 0.00%7.33M | --7.33M | ---- | ---- |
Financial expense | -5.36%10.45M | --11.04M | ---- | ---- |
Operating profit before the change of operating capital | 39.71%136.68M | 125,525.64%97.83M | 63.89%-78K | ---216K |
Change of operating capital | ||||
Accounts receivable (increase)decrease | -161.28%-74.83M | ---28.64M | ---- | ---- |
Accounts payable increase (decrease) | 569.15%79.12M | -56,313.33%-16.86M | 50.00%30K | --20K |
prepayments (increase)decrease | -172.09%-21.91M | 608,040.00%30.4M | ---5K | ---- |
Special items for working capital changes | ---275K | ---- | ---- | ---- |
Cash from business operations | 43.58%118.78M | 156,188.68%82.73M | 72.96%-53K | ---196K |
Other taxs | -366.13%-13.77M | ---2.96M | ---- | ---- |
Interest received - operating | 122.51%781K | 2,093.75%351K | 433.33%16K | --3K |
Net cash from operations | 32.03%105.79M | 216,648.65%80.12M | 80.83%-37K | ---193K |
Cash flow from investment activities | ||||
Interest received - investment | -76.32%103K | --435K | ---- | ---- |
Loan receivable (increase) decrease | 212.42%25.97M | ---23.1M | ---- | ---- |
Sale of fixed assets | -79.58%29K | --142K | ---- | ---- |
Purchase of fixed assets | 14.00%-1.46M | ---1.7M | ---- | ---- |
Sale of subsidiaries | --12M | ---- | ---- | ---- |
Acquisition of subsidiaries | ---- | 89.60%-2.22M | ---21.32M | ---- |
Recovery of cash from investments | -64.45%22.93M | --64.5M | ---- | ---- |
Cash on investment | 57.14%-19.93M | ---46.5M | ---- | ---25M |
Net cash from investment operations | 569.55%39.64M | 60.40%-8.44M | 14.72%-21.32M | ---25M |
Net cash before financing | 102.88%145.43M | 435.63%71.68M | 15.23%-21.36M | ---25.19M |
Cash flow from financing activities | ||||
New borrowing | 80.03%76.29M | --42.38M | ---- | ---- |
Refund | -380.39%-65.76M | ---13.69M | ---- | ---- |
Interest paid - financing | -14.21%-1.63M | ---1.43M | ---- | ---- |
Dividends paid - financing | ---23M | ---- | ---- | ---- |
Absorb investment income | --20M | ---- | 14.29%8K | --7K |
Other items of the financing business | -211.77%-2.62M | -93.31%2.35M | -41.75%35.07M | --60.21M |
Net cash from financing operations | -315.61%-37.46M | -125.70%-9.01M | -41.75%35.08M | --60.21M |
Effect of rate | 52.47%988K | --648K | ---- | ---- |
Net Cash | 72.28%107.97M | 356.76%62.67M | -60.82%13.72M | --35.02M |
Begining period cash | 129.90%112.06M | 39.18%48.74M | --35.02M | ---- |
Cash at the end | 97.23%221.01M | 129.90%112.06M | 39.18%48.74M | --35.02M |
Cash balance analysis | ||||
Currency Unit | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |
Auditor | Ernst & Young | Ernst & Young | Ernst & Young | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data